The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,860.00
Bid: 1,860.00
Ask: 1,872.00
Change: -8.00 (-0.43%)
Spread: 12.00 (0.645%)
Open: 1,830.00
High: 1,890.00
Low: 1,830.00
Prev. Close: 1,868.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Award for Incoming CEO

2 May 2023 07:00

RNS Number : 9825X
Genus PLC
02 May 2023
 

For Immediate Release 2 May 2023

Genus plc('Genus', or the 'Company')

Share Award for Incoming CEO

Further details on appointment of Chief Executive Officer

Disclosed below are the agreed reward arrangements for Jorgen Kokke, which are consistent with our shareholder approved Remuneration Policy.

 

He will be paid a basic annual salary of US$825,000. He will additionally receive a pension contribution worth 6% of this salary.

 

Jorgen will also receive payments following appointment of c£4m, the majority of which will be made in Genus share awards with future vesting dates subject to continued employment and which are set out below. These awards, which will be granted over Genus shares, are for loss of compensation of incentives held at Ingredion, the valuation of which has been determined in line with our Remuneration Policy, and which will be fully disclosed in our Annual Report. 

 

His ongoing variable reward opportunity will be structured as follows:

· An annual bonus opportunity of up to 200% of salary, with compulsory deferment of one-third of any bonus paid into shares, to be held for a minimum period of 3 years.

· In September 2023 (only) we will use the exceptional limit available within our Remuneration Policy to make a long term incentive award of 400% of salary under the Performance Share Plan (PSP). These awards will vest after three years subject to achievement against company performance targets, and will be subject to a further two year holding period following vesting. 

· In future years, expected to be from September 2024 onwards, long term awards will be in line with the standard level permissible our Remuneration Policy (currently 200% of salary). 

 

In addition to the above changes the Company provides the following updates:

· Further to the announcement of the forthcoming retirement of Stephen Wilson on 30 September, the Remuneration Committee has determined that Stephen will be treated as a good leaver from the business. The approach to reward will be in line with our agreed Remuneration Policy and we will make full disclosures as required under Section 430(2b) at the point of leaving and within our next Annual Report.

· Following determination of her future role and responsibilities and a market review of compensation, the Committee have decided to increase the salary for Alison Henriksen to £480,930 effective 1 July 2023. No further increases will be made in September 2023 or September 2024 with next scheduled review in September 2025. In reaching this decision the Board have considered and redefined the scope of the role that will be performed by Alison following the appointment of Jorgen Kokke. In particular, this will reflect the fact that she will be the sole Executive Director based primarily in the UK following the change of CEO. The Committee view this aspect as an extension of her current role, and this is reflected within the revised salary level that will be payable.

 

This announcement is made in accordance with Listing Rule 9.6.11R.

 

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that on 2 May 2023, Jorgen Kokke was granted awards of shares in respect of buyout of compensation forfeited from Ingredion as a result of his resignation. These have been awarded in line with the Company's Remuneration Policy, which is set out in our latest Annual Report.

 

These awards have been granted pursuant to Listing Rule 9.4.2R as nil-cost share options over ordinary shares on substantially similar terms to the Genus 2019 Performance Share Plan ('PSP'), but without further Genus company performance conditions and have been determined to be a fair value for awards that have been forfeited at Ingredion, with vesting dates designed to mirror the operation of those awards where applicable. Further details of the approach adopted by the Committee to determination of this value will be provided in our Annual Report. 

 

Date of Grant

Number of Nil-Cost Options Granted

Scheduled Vesting Date

2 May 2023

59,055

23 February 2024

2 May 2023

7,649

2 May 2024

2 May 2023

44,933

28 February 2025

2 May 2023

7,649

2 May 2025

2 May 2023

7,649

4 May 2026

 

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail of the nil-cost option awards made on 2 May 2023.

 

For further information please contact:

 

 

Genus:

Dan Hartley, Group General Counsel and Company Secretary Tel: +44 (0)1256 347100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table A - Buy-out of Ingredion awards vesting on 23 February 2024

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer designate

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

 

Price

 

Volume

0p

59,055

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-05-02

f.

Place of the transaction

Outside a trading venue.

 

 

Table B - Buy-out of Ingredion awards vesting on 2 May 2024

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer designate

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

 

Price

 

Volume

0p

7,649

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-05-02

f.

Place of the transaction

Outside a trading venue.

 

 

Table C - Buy-out of Ingredion awards vesting on 28 February 2025

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer designate

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

 

Price

 

Volume

0p

44,933

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-05-02

f.

Place of the transaction

Outside a trading venue.

 

 

Table D - Buy-out of Ingredion awards vesting on 2 May 2025

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer designate

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

 

Price

 

Volume

0p

7,649

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-05-02

f.

Place of the transaction

Outside a trading venue.

 

 

Table E - Buy-out of Ingredion awards vesting on 4 May 2026

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer designate

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

 

Price

 

Volume

0p

7,649

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-05-02

f.

Place of the transaction

Outside a trading venue.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSMFAFEDSEFI
Date   Source Headline
28th Jun 20215:00 pmRNSPIC AND SERGAL ENTER INTO STRATEGIC RELATIONSHIP
22nd Jun 20217:00 amRNSCapital Markets Event & PRRSv Programme Update
14th Jun 20213:01 pmRNSNotification of Major Holdings
7th Jun 202110:42 amRNSApplication For Additional Listing
4th Jun 20214:38 pmRNSNotification of Major Holdings
17th May 20211:23 pmRNSNotification of Major Holdings
13th May 202110:50 amRNSDirector/PDMR Shareholding
9th Apr 20214:10 pmRNSDirector/PDMR Shareholding
6th Apr 20216:00 pmRNSDirector/PDMR Shareholding
1st Apr 20215:49 pmRNSTotal Voting Rights
31st Mar 20212:59 pmRNSDirector/PDMR Shareholding
22nd Mar 20217:00 amRNSBoard Changes
19th Mar 202112:20 pmRNSDirector/PDMR Shareholding
9th Mar 20215:41 pmRNSNotification of Major Holdings
3rd Mar 20215:19 pmRNSDirector/PDMR Shareholding
26th Feb 202112:39 pmRNSDirector/PDMR Shareholding
25th Feb 20217:00 amRNSInterim Results
1st Feb 202111:08 amRNSBlock listing Interim Review
1st Feb 202111:08 amRNSTotal Voting Rights
18th Jan 20217:00 amRNSTrading Update
2nd Dec 20205:44 pmRNSDirector/PDMR Shareholding
25th Nov 20201:13 pmRNSResult of AGM
25th Nov 20207:00 amRNSAGM Trading Update - Strong Performance Continues
11th Nov 20201:03 pmRNSNOTIFICATION OF MAJOR HOLDINGS
16th Oct 20208:00 amRNSAnnual Report and Annual General Meeting
1st Oct 20203:45 pmRNSTotal Voting Rights
25th Sep 20206:14 pmRNSDirector/PDMR Shareholding
23rd Sep 20209:35 amRNSDirector/PDMR Shareholding
16th Sep 202012:16 pmRNSDirector/PDMR Shareholding
15th Sep 20205:52 pmRNSDirector/PDMR Shareholding
9th Sep 202012:17 pmRNSNOTIFICATION OF MAJOR HOLDINGS
8th Sep 20203:16 pmRNSApplication for Additional Listing
8th Sep 20207:00 amRNSPreliminary Results
1st Sep 20201:03 pmRNSTotal Voting Rights
3rd Aug 20204:15 pmRNSBlock listing Interim Review
1st Jul 202010:41 amRNSTotal Voting Rights
30th Jun 20203:45 pmRNSNOTIFICATION OF MAJOR HOLDINGS
29th Jun 20207:00 amRNSDirectorate Appointment
14th May 20206:23 pmRNSApplication for Block Listing
1st May 20203:04 pmRNSTotal Voting Rights
30th Apr 202010:24 amRNSCompliance with LR 9.2.6ER(1)
22nd Apr 20205:47 pmRNSDirector/PDMR Shareholding
21st Apr 202012:14 pmRNSNotification of Major Holdings
20th Apr 20209:28 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
1st Apr 20205:52 pmRNSTotal Voting Rights
27th Feb 20207:00 amRNSInterim Results
26th Feb 202012:44 pmRNSNOTIFICATION OF MAJOR HOLDINGS
17th Feb 20205:27 pmRNSNotification of Major Holdings
7th Feb 20209:03 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.